1. Home
  2. News
  3. News
  4. A memorandum of Understanding (MOU) with Macter International Limited in Pakistan for the authorization and distribution of the new drug AD17002-SC for COVID-19.

A memorandum of Understanding (MOU) with Macter International Limited in Pakistan for the authorization and distribution of the new drug AD17002-SC for COVID-19.

A memorandum of Understanding (MOU) with Macter International Limited in Pakistan for the authorization and distribution of the new drug AD17002-SC for COVID-19.
2021-09-27
Back
繁體中文
English
简体中文
This site uses cookies to collect the necessary user browsing behavior so that we can provide you with a better browsing experience. Browse this site, which means you agree with "online privacy declaration."